
India’s first dengue vaccine Qdenga set for private market availability by mid-2027
The story in brief
India’s first approved dengue vaccine, Qdenga, is expected to be available in the private market by mid-2027, pending regulatory and quality processes. Marketing authorization was granted by CDSCO in July 2026 for ages 4 to 60. Dr Reddy’s will distribute it, using a weakened DENV-2 virus with structural proteins from other serotypes. Takeda aims to include it in India’s public immunisation programme.